Seguir
Anil K.Philip
Título
Citado por
Citado por
Año
Colon targeted drug delivery systems: a review on primary and novel approaches
AK Philip, B Philip
Oman medical journal 25 (2), 79, 2010
5222010
Modified transdermal technologies: Breaking the barriers of drug permeation via the skin
R Kumar, A Philip
Tropical journal of pharmaceutical research 6 (1), 633-644, 2007
3322007
Drug delivery: principles and applications
B Wang, L Hu, TJ Siahaan
John Wiley & Sons, 2016
2642016
Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility
AK Philip, K Pathak
Aaps Pharmscitech 7, E1-E11, 2006
1032006
Dendrimers: Nanotechnology derived novel polymers in drug delivery
S Pushkar, A Philip, K Pathak, D Pathak
Indian Journal of Pharmaceutical Education and Research 40 (3), 153, 2006
822006
Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis
AK Philip, S Dabas, K Pathak
Journal of drug targeting 17 (3), 235-241, 2009
812009
Gastroretentive dosage forms for prolonging gastric residence time
R Kumar, A Philip
International Journal of Pharmaceutical Medicine 21, 157-171, 2007
762007
Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin
J Singh, AK Philip, K Pathak
Aaps Pharmscitech 9, 60-66, 2008
732008
Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil
AK Philip, K Pathak, P Shakya
European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 658-666, 2008
692008
Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach
AK Philip, RK Dubey, K Pathak
Journal of Pharmacy and Pharmacology 60 (5), 607-613, 2008
572008
Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug
AK Philip, K Pathak
Drug development and industrial pharmacy 34 (7), 735-743, 2008
562008
Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin
V Sharma, AK Philip, K Pathak
Aaps Pharmscitech 9, 87-94, 2008
552008
Global burden of cardiovascular diseases and risks, 1990-2022
GA Mensah, V Fuster, CJL Murray, GA Roth, AK Philip
Journal of the American College of Cardiology, 2350-2473, 2023
512023
Bioptome‐assisted coil occlusion of moderate‐large patent ductus arteriosus in infants and small children
RK Kumar, SR Anil, BRJ Kannan, A Philip, K Sivakumar
Catheterization and cardiovascular interventions 62 (2), 266-271, 2004
472004
Clinical course and management strategies for hemolysis after transcatheter closure of patent arterial ducts
SR Anil, K Sivakumar, AK Philip, E Francis, RK Kumar
Catheterization and cardiovascular interventions 59 (4), 538-543, 2003
462003
In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug
A Philip, K Pathak
PDA Journal of Pharmaceutical Science and Technology 61 (1), 24-36, 2007
432007
Colon targeted drug delivery systems: a review on primary and novel approaches, Oman Med
AK Philip, B Philip
J 25 (2), 79-87, 2010
202010
Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability
AK Philip, M Srivastava, K Pathak
Drug Delivery 16 (7), 405-415, 2009
202009
Artificial Intelligence and Precision Medicine: A New Frontier for the Treatment of Brain Tumors
AK Philip, BA Samuel, S Bhatia, SAM Khalifa, HR El-Seedi
Life 13 (1), 24, 2022
192022
Chronopharmaceuticals: hype or future of pharmaceutics
A K Philip, B Philip
Current pharmaceutical design 17 (15), 1512-1516, 2011
192011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20